Trending Technology  |  Novel Networks & Finance  |  Produce & Use
 LIVE ONLINE 7 October 2021
Advanced Therapies Integrates Speakers 2021
SHARON BROWNLOW
Chief Business Officer
Cell & Gene Therapy Catapult
TONY KHOURY
Executive Vice President
Project Farma
JANE THEAKER
Chief Executive Officer
Kinomica
JOE HEALY
Chief Executive Officer and
Co-Founder
NanoSyrinx
JAMES STRACHAN
 Editor
The Cell + Gene Curator
CHARLOTTE CASEBOURNE
Co-Founder & Chief Executive Officer
Theolytic
STEPHEN WARD
Chief Manufacturing Officer
Cell and Gene Therapy Catapult
BAKUL GUPTA
Chief Executive Officer and Co-founder
ImmTune Therapies
NICK STEPHENS
Executive Chairman
The RSA Group
ROUDIE SHAFIE
Director
OVID Health
CHRIS NOWERS
Chief Executive Officer
ONK Therapeutics
NATHAN SIGWORTH
Co-founder and Chief Executive Officer
PharmaCCX
NAZNEEN RAHMAN CBE
Non-Executive Director
AstraZeneca
SVEN KILI
Chief Executive Officer
Antion Biosciences
CAROLE LONGSON
Independent Senior Adviser
Life Science Policy, HTA and Market Access
DAVID BLAKEY
Senior Vice President Strategic Alliances
MiNA Therapeutics
FIONA THISTLETHWAITE
Medical Oncology Consultant
The Christie NHS Foundation Trust
JASON MELLAD
Chief Executive Officer
Start Codon
BRIAN HARRISON
Managing Director
HiTech Health
SARAH BRUCE-WHITE
Partnerships & Programme’s Lead
MedCity
BRUCE LEVINE
Founding Director
Clinical Cell and Vaccine Production Facility
STEVE McCONCHIE
Chief Executive Officer
Aptus Clinical
JAMES KUSENA
Head of Bioprocessing
MicrofluidX
TAMAS MASZTIS
Senior Director, Cell Therapy Supply Chain for Europe
Kite, a Gilead Company
SIMON PEGG
Director
Project-Ion
FABIO D’AGOSTINO
Venture Partner
Claris Ventures SGR
ALASTAIR THONG
Founder
Selvedge Venture
MALCOLM BARRATT-JOHNSON
Managing Director
PharmaMedic Consultancy Ltd
JASON C. FOSTER
Chief Executive Officer and Executive Director
Ori Biotech
STEPHEN LITTLE
Vice Chairman
Yourgene Health
ERIC HALIOUA
President & Chief Executive Officer
PDC*line Pharma
SALLY ANN FORSYTH OBE
Chief Executive Officer
Stevenage Bioscience Catalyst
FERNANDA MASRI
Head of Commercial for the Manufacturing Centre
Cell and Gene Therapy Catapult
TERRI GASKELL
Chief Technical Officer
Rinri Therapeutics Ltd.
JENNY LAIRD
Vice President, Search & Evaluation Pain & Neurodegeneration
Eli Lilly and Company
KASIA AVERALL
Head of Cluster Development
Cell and Gene Therapy Catapult
JAMES FRY
Partner and Head of Life Sciences
Mills & Reeve
LEE CONEY
Head of Non-Clinical Safety
Cell and Gene Therapy Catapult
COLIN MACKAY
Founder and Chief Executive Officer
Symbiosis Pharmaceutical Services
MARTINO PICARDO
Chairman
Discovery Park
JESÚS ZURDO
Global Head Cell, Gene Therapy & Bioproduction
Horizon Discovery
ANTHONY WILSON
Consultant in Anaesthesia and Critical Care
Manchester University NHS Foundation Trust
LUCY FOLEY
Director of Biologics
CPI
ROBERT JONES
Vice President, Global BioServices
Cryoport Systems
TIM LUKER
Vice President Emerging Technology and Innovation
Eli Lilly
TIMOTHY NEWTON
Founder and Chief Executive Officer
Reflection Therapeutics
BILL SHINGLETON
Director, Applications and Biology: Cell and Gene Therapy
Cytiva
KEITH FOSTER
Chief Scientific Officer
Sutura Therapeutics
JAMES GREGORY
Managing Partner
The RSA Group
EMILY MERRELL
Interim Head of ATTC Network Coordination
Cell and Gene Therapy Catapult
JANE KENNEDY
Chief Business Officer
Discovery Park
CLAIRE THOMPSON
Chief Executive Officer
Agility Life Sciences
MARK FOWLER
Global Head of Procurement & Sourcing
Autolus Therapeutics
MARY JONES
Deputy Director for Strategy, Investment and Manufacturing
Office for Life Sciences
BILL SCOTT
Scientific Director, Transplant Regenerative Medicine
Newcastle University Medical School
KATE COLEMAN
Senior Director and Principal Consultant
PharmaLex
AHMED BOUZIDI
Vice-President Biotech
ProductLife Group
DAN PEARCE
Vice President, European Manufacturing & Technical Operations
Adaptimmune
WILL ROHLEDER
Development Director
Reef
CLARE HAGUE
Therapy Area Market Access Lead, Hematology (EMEA)
Janssen
KEVIN BRUCE
Chief Operating Officer
Roslin Cell Therapies Ltd
AGATHE GUILLOT
Head of Regulatory Affairs
Cell and Gene Therapy Catapult
STEVEN TAIT
Senior business manager
LifeArc
GAVIN LEWIS
Vice President, Global Value and Access
Amgen (Europe) GmbH
HARVEY BRANTON
Technology Lead
CPI Biologics
MARIAN REVIRIEGO
Co-Founder, Executive Regulatory Affairs Consultant
Alladvice Regulatory Consultants
NADINE CLEMO
Project Director
Apollo Therapeutics
SADIA L’BAOUCH
Chief Technical Officer, Vice President
Ixaka
RANJEEVA RANASINGHE
Product Director, Cell and Gene Therapy
GSK
KATE ROWLEY
Venture Partner
Global Bio Fund
Trending Technology  |  Novel Networks & Finance  |  Produce & Use